Rockwell Deferred Long Term Liab vs Total Assets Analysis
RMTI Stock | USD 2.20 0.13 5.58% |
Rockwell Medical financial indicator trend analysis is much more than just breaking down Rockwell Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rockwell Medical is a good investment. Please check the relationship between Rockwell Medical Deferred Long Term Liab and its Total Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
Deferred Long Term Liab vs Total Assets
Deferred Long Term Liab vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rockwell Medical Deferred Long Term Liab account and Total Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Rockwell Medical's Deferred Long Term Liab and Total Assets is 0.78. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Total Assets in the same time period over historical financial statements of Rockwell Medical, assuming nothing else is changed. The correlation between historical values of Rockwell Medical's Deferred Long Term Liab and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Rockwell Medical are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Deferred Long Term Liab i.e., Rockwell Medical's Deferred Long Term Liab and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.78 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Total Assets
Total assets refers to the total amount of Rockwell Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rockwell Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Rockwell Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rockwell Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.As of now, Rockwell Medical's Enterprise Value is decreasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 27.9M | 20.9M | 15.4M | 19.7M | Cost Of Revenue | 64.4M | 68.7M | 74.9M | 41.4M |
Rockwell Medical fundamental ratios Correlations
Click cells to compare fundamentals
Rockwell Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rockwell Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 44.3M | 77.7M | 48.6M | 46.6M | 52.2M | 37.3M | |
Other Current Liab | 4.8M | 5.3M | 5.2M | 7.8M | 9.9M | 10.4M | |
Total Current Liabilities | 12.4M | 12.8M | 21.0M | 17.7M | 16.6M | 9.7M | |
Total Stockholder Equity | 20.3M | 34.2M | 2.5M | 14.1M | 21.3M | 19.2M | |
Property Plant And Equipment Net | 5.6M | 5.6M | 10.2M | 8.6M | 11.0M | 11.6M | |
Net Debt | (7.8M) | (24.7M) | 15.6M | (5.1M) | 4.5M | 4.7M | |
Retained Earnings | (306.5M) | (337.4M) | (370.1M) | (388.8M) | (397.2M) | (377.3M) | |
Accounts Payable | 3.0M | 4.2M | 3.7M | 4.1M | 4.5M | 4.1M | |
Cash | 11.8M | 48.7M | 13.3M | 21.5M | 9.0M | 13.5M | |
Non Current Assets Total | 7.4M | 8.3M | 13.3M | 11.3M | 23.4M | 24.6M | |
Non Currrent Assets Other | 875.9K | 1.8M | 2.1M | 1.8M | 705K | 1.1M | |
Cash And Short Term Investments | 26.0M | 58.7M | 22.4M | 21.5M | 10.9M | 10.4M | |
Net Receivables | 4.2M | 4.2M | 5.9M | 6.3M | 10.9M | 11.4M | |
Common Stock Shares Outstanding | 5.5M | 6.9M | 8.5M | 9.9M | 23.3M | 24.5M | |
Liabilities And Stockholders Equity | 44.3M | 77.7M | 48.6M | 46.6M | 52.2M | 37.3M | |
Inventory | 3.6M | 3.9M | 4.1M | 5.8M | 5.9M | 3.8M | |
Other Current Assets | 3.0M | 2.7M | 2.9M | 1.7M | 1.1M | 1.1M | |
Other Stockholder Equity | 326.8M | 371.5M | 372.6M | 402.7M | 418.5M | 439.4M | |
Total Liab | 24.0M | 43.6M | 46.0M | 32.5M | 30.9M | 18.1M | |
Property Plant And Equipment Gross | 5.6M | 2.6M | 17.3M | 16.2M | 19.8M | 20.8M | |
Total Current Assets | 36.9M | 69.5M | 35.3M | 35.3M | 28.8M | 31.1M | |
Accumulated Other Comprehensive Income | 52.0K | 57K | 52K | 163K | (1K) | (1.1K) | |
Short Term Debt | 2.3M | 1.2M | 9.8M | 4.1M | 2.2M | 1.8M | |
Common Stock | 299.6M | 6.5K | 9K | 1K | 3K | 2.9K | |
Intangible Assets | 4.0K | 3.7K | 3.3K | 10.8M | 12.4M | 13.0M | |
Common Stock Total Equity | 273.2M | 299.6M | 6.5K | 9K | 10.4K | 9.8K | |
Other Assets | 875.9K | 4.7M | 2.1M | 13.8M | 15.9M | 16.7M | |
Short Term Investments | 14.3M | 10.0M | 9.2M | 11.4M | 2.0M | 1.9M | |
Non Current Liabilities Total | 11.6M | 30.8M | 25.1M | 14.8M | 14.2M | 9.8M | |
Property Plant Equipment | 2.9M | 5.6M | 10.2M | 8.6M | 9.9M | 10.4M | |
Current Deferred Revenue | 2.3M | 2.3M | 2.3M | 1.8M | 46K | 43.7K | |
Net Tangible Assets | 19.4M | 33.2M | 1.6M | 13.2M | 11.9M | 20.7M | |
Retained Earnings Total Equity | (240.3M) | (272.4M) | (306.5M) | (337.4M) | (303.7M) | (318.8M) | |
Other Liab | 9.8M | 8.0M | 6M | 2.6M | 2.4M | 2.2M |
Currently Active Assets on Macroaxis
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 3.041 | Quarterly Revenue Growth 0.429 | Return On Assets (0.04) | Return On Equity (0.29) |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.